Explore the words cloud of the CAPPERAM project. It provides you a very rough idea of what is the project "CAPPERAM" about.
The following table provides information about the project.
SEDECAL MOLECULAR IMAGING SL
|Coordinator Country||Spain [ES]|
|Total cost||170˙121 €|
|EC max contribution||170˙121 € (100%)|
1. H2020-EU.1.3.2. (Nurturing excellence by means of cross-border and cross-sector mobility)
|Duration (year-month-day)||from 2018-12-01 to 2020-11-30|
Take a look of project's partnership.
|1||SEDECAL MOLECULAR IMAGING SL||ES (MADRID)||coordinator||170˙121.00|
In radiation therapy, proton therapy has a more favourable dose distribution than conventional radiotherapy with photons and electrons. However, in order to fully exploit this dosimetric advantage, it would be required to verify the range of protons in the patient with mm accuracy. The most used strategy for in-vivo range verification in protontherapy relies on positron emission tomography (PET) activation. As they progress through the patient, proton beams undergo nuclear reactions than can produce radioactive isotopes, some of which are positron-emitters. This induced radiactivity can be detected in commercial or dedicated PET scanners and used to deduce the delivered dose distribution in the patient.
While a promising technique, two main challenges have so far limited its clinical implementation: first, the proton interaction cross sections of the elements making up the body (C, O, N, H) are relatively low, which causes the positron dissintegration counts detected by the PET scanners to be about 1 or 2 orders of magnitude lower than the usual numbers in nuclear medicine. And second, the spatial and temporal distributions of PET emitters follow a very complex relation with the dose depositions which complicate the range verification process.
The CAPPERAM project aims at solving these two problems by using Zn-based contrast agents in the patient during irradiation. Zn has a very high cross section for proton interaction peaking at very low proton energies, which produces a very high concentration of PET emitters near the end of the proton range.
The action, comprising both computational simulations and phantom experiments, will take place in Sedecal Molecular Imaging, a company dedicated to the fabrication of high-precision PET devices, with a 6-month secondment at the group of Nuclear Physics of the Complutense University in Madrid, which specializes in applications of experimental nuclear physics to medical imaging.
Are you the coordinator (or a participant) of this project? Plaese send me more information about the "CAPPERAM" project.
For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.
Send me an email (email@example.com) and I put them in your project's page as son as possible.
Thanks. And then put a link of this page into your project's website.
The information about "CAPPERAM" are provided by the European Opendata Portal: CORDIS opendata.
Sexual selection in plants: testing new ideas on the perception of the mating environment and on the mate choice physiologyRead More
Tensoring Positive Maps on Operator StructuresRead More
INTERACTIONS OF ROOT PHENOTYPES AND ROOT MICROBIOME IN MAIZE UNDER NITROGEN LIMITING CONDITIONSRead More